{"transactions":[{"id":1943166,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":115313,"kind":"person","name":"Miller Matthew P","position":1,"cik":"0001915822","reported_name":"Miller Matthew P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-03-22T00:56:03.000Z","date":"2023-03-17","kind":"grant","planned":false,"acquired":true,"shares":169169,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest as to 1/4th of the options granted on the first anniversary of the Vesting Commencement Date, with the remaining options vesting in four equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all options becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates."}],"balance_after":169169,"derivative":{"exercise_price":0.481,"expiration_date":"2033-03-17","underlying":"Common stock","underlying_shares":169169},"source":{"system":"sec-edgar","filing":"0001628280-23-008832","document":"wf-form4_167944655124135.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000162828023008832/wf-form4_167944655124135.xml","form_type":"4"}},{"id":1943165,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":115313,"kind":"person","name":"Miller Matthew P","position":1,"cik":"0001915822","reported_name":"Miller Matthew P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common stock","published_at":"2023-03-22T00:56:03.000Z","date":"2023-03-17","kind":"grant","planned":false,"acquired":true,"shares":67667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents RSUs with 1/4th of the RSUs vesting on the anniversary of March 17, 2023 (the Vesting Commencement Date), with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates."}],"balance_after":242992,"source":{"system":"sec-edgar","filing":"0001628280-23-008832","document":"wf-form4_167944655124135.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000162828023008832/wf-form4_167944655124135.xml","form_type":"4"}},{"id":2079921,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":115313,"kind":"person","name":"Miller Matthew P","position":1,"cik":"0001915822","reported_name":"Miller Matthew P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-12-21T01:07:11.000Z","date":"2022-12-16","kind":"purchase","acquired":true,"shares":73684,"price":0.95,"value":69999.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchase of common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 577 shares, with the reporting persons sale of shares of common stock on November 15, 2022. The reporting person has paid to the Issuer the full amount of the profit realized in connection with the short-swing transaction, less transaction costs, calculated in accordance with Section 16(b)."}],"balance_after":175325,"source":{"system":"sec-edgar","filing":"0001799191-22-000058","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000179919122000058/edgardoc.xml","form_type":"4"}},{"id":2107026,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":115313,"kind":"person","name":"Miller Matthew P","position":1,"cik":"0001915822","reported_name":"Miller Matthew P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-11-23T01:07:41.000Z","date":"2022-11-15","kind":"sale","acquired":false,"shares":577,"price":2.0277,"value":1169.9829,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4/A amends and restates the reporting persons Form 4 originally filed on November 17, 2022 in the entirety. This Form 4/A is being filed to correct the reporting persons original Form 4 from Code D to Code S. The sales reported in the Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price is the volume weighted average selling price of all sales by the Reporting Person on November 15, 2022 within a one-dollar range. Actual prices ranged from $2.022 to $2.028. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price."}],"balance_after":78034,"source":{"system":"sec-edgar","filing":"0001799191-22-000051","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000179919122000051/edgardoc.xml","form_type":"4/A","original_submission_date":"2022-11-17"}},{"id":2108727,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":115313,"kind":"person","name":"Miller Matthew P","position":1,"cik":"0001915822","reported_name":"Miller Matthew P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-11-21T22:33:35.000Z","date":"2022-11-17","kind":"grant","acquired":true,"shares":119825,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest as to 1/4th of the options granted on the first anniversary of the Vesting Commencement Date, with the remaining options vesting in four equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all options becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates."}],"balance_after":119825,"derivative":{"exercise_price":1.87,"expiration_date":"2032-11-17","underlying":"Common Stock","underlying_shares":119825},"source":{"system":"sec-edgar","filing":"0001799191-22-000037","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000179919122000037/edgardoc.xml","form_type":"4"}},{"id":2108726,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":115313,"kind":"person","name":"Miller Matthew P","position":1,"cik":"0001915822","reported_name":"Miller Matthew P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-11-21T22:33:35.000Z","date":"2022-11-17","kind":"grant","acquired":true,"shares":23607,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents RSUs with 1/4th of the RSUs vesting on the anniversary of November 17, 2022 (the Vesting Commencement Date), with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates."}],"balance_after":101641,"source":{"system":"sec-edgar","filing":"0001799191-22-000037","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000179919122000037/edgardoc.xml","form_type":"4"}},{"id":2112325,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":115313,"kind":"person","name":"Miller Matthew P","position":1,"cik":"0001915822","reported_name":"Miller Matthew P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-11-17T22:30:53.000Z","date":"2022-11-15","kind":"disposition_to_issuer","acquired":false,"shares":577,"price":2.0277,"value":1169.9829,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price is the volume weighted average selling price of all sales by the Reporting Person on November 15, 2022 within a one-dollar range. Actual prices ranged from $2.022 to $2.028. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price."}],"balance_after":78034,"source":{"system":"sec-edgar","filing":"0001799191-22-000013","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000179919122000013/edgardoc.xml","form_type":"4"}},{"id":2315416,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":115313,"kind":"person","name":"Miller Matthew P","position":1,"cik":"0001915822","reported_name":"Miller Matthew P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-30T00:11:35.000Z","date":"2022-03-21","kind":"grant","acquired":true,"shares":109844,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest as to 1/3rd of the options granted on the second anniversary of the Vesting Commencement Date, with the remaining options vesting in four equal annual installments beginning on the third anniversary of the Vesting Commencement Date, with all options becoming vested on the sixth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates."}],"balance_after":109844,"derivative":{"exercise_price":7.09,"expiration_date":"2032-03-21","underlying":"Common stock","underlying_shares":109844},"source":{"system":"sec-edgar","filing":"0001628280-22-007763","document":"wf-form4a_164859908108007.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000162828022007763/wf-form4a_164859908108007.xml","form_type":"4/A","original_submission_date":"2022-03-23"}},{"id":2315415,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":115313,"kind":"person","name":"Miller Matthew P","position":1,"cik":"0001915822","reported_name":"Miller Matthew P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-30T00:11:35.000Z","date":"2022-03-21","kind":"grant","acquired":true,"shares":32417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest in four equal annual installments on each of the first four anniversaries of November 12, 2021 (the \"Vesting Commencement Date\"), with all options becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates."}],"balance_after":32417,"derivative":{"exercise_price":7.09,"expiration_date":"2032-03-21","underlying":"Common stock","underlying_shares":32417},"source":{"system":"sec-edgar","filing":"0001628280-22-007763","document":"wf-form4a_164859908108007.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000162828022007763/wf-form4a_164859908108007.xml","form_type":"4/A","original_submission_date":"2022-03-23"}},{"id":2320124,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":115313,"kind":"person","name":"Miller Matthew P","position":1,"cik":"0001915822","reported_name":"Miller Matthew P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-23T23:34:59.000Z","date":"2022-03-21","kind":"grant","acquired":true,"shares":17575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock options vest as to 1/3rd of the options granted on the second anniversary of the Vesting Commencement Date, with the remaining options vesting in four equal annual installments beginning on the third anniversary of the Vesting Commencement Date, with all options becoming vested on the sixth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates."}],"balance_after":17575,"derivative":{"exercise_price":7.09,"expiration_date":"2032-03-21","underlying":"Common stock","underlying_shares":17575},"source":{"system":"sec-edgar","filing":"0001628280-22-007095","document":"wf-form4_164807848351583.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000162828022007095/wf-form4_164807848351583.xml","form_type":"4"}},{"id":2320123,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":115313,"kind":"person","name":"Miller Matthew P","position":1,"cik":"0001915822","reported_name":"Miller Matthew P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-23T23:34:59.000Z","date":"2022-03-21","kind":"grant","acquired":true,"shares":5186,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options vest in four equal annual installments on each of the first four anniversaries of the Vesting Commencement Date, with all options becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates."}],"balance_after":5186,"derivative":{"exercise_price":7.09,"expiration_date":"2032-03-21","underlying":"Common stock","underlying_shares":5186},"source":{"system":"sec-edgar","filing":"0001628280-22-007095","document":"wf-form4_164807848351583.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000162828022007095/wf-form4_164807848351583.xml","form_type":"4"}},{"id":2320122,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":115313,"kind":"person","name":"Miller Matthew P","position":1,"cik":"0001915822","reported_name":"Miller Matthew P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common stock","published_at":"2022-03-23T23:34:59.000Z","date":"2022-03-21","kind":"grant","acquired":true,"shares":21641,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents RSUs with 1/3rd of the RSUs vesting on the second anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in four equal annual installments beginning on the third anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the sixth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents RSUs with 1/3rd of the RSUs vesting on the second anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in four equal annual installments beginning on the third anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the sixth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates."}],"balance_after":78611,"source":{"system":"sec-edgar","filing":"0001628280-22-007095","document":"wf-form4_164807848351583.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000162828022007095/wf-form4_164807848351583.xml","form_type":"4"}},{"id":2320121,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":115313,"kind":"person","name":"Miller Matthew P","position":1,"cik":"0001915822","reported_name":"Miller Matthew P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common stock","published_at":"2022-03-23T23:34:59.000Z","date":"2022-03-21","kind":"grant","acquired":true,"shares":6386,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that vest in four equal annual installments on each of the first four anniversaries of November 12, 2021 (the \"Vesting Commencement Date\"), with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (\"RSUs\") that vest in four equal annual installments on each of the first four anniversaries of November 12, 2021 (the \"Vesting Commencement Date\"), with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates."}],"balance_after":56970,"source":{"system":"sec-edgar","filing":"0001628280-22-007095","document":"wf-form4_164807848351583.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000162828022007095/wf-form4_164807848351583.xml","form_type":"4"}}]}